DeepMed Research

Nanjing Medical University First Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

IVUS-guided DES Implantation in Coronary Calcification

Not Applicable

Recruiting

Conditions: Coronary Artery Disease

Interventions: Procedure: Intravascular ultrasound
Procedure: Angiography

First Posted Date: 2023-04-05

Last Posted Date: 2024-11-15

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 864

Registration Number: NCT05800002

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

The Alteration of Gut Microbiota and Analysis of Related Factors in Newly Diagnosed Type 2 Diabetes Patients

Recruiting

Conditions: Type 2 Diabetes

First Posted Date: 2023-03-03

Last Posted Date: 2023-03-03

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 60

Registration Number: NCT05752851

Locations: 🇨🇳
Nanjing First hospital, Nanjing, Jiangsu, China

Application of Intraoperative Transesophageal Echocardiography Imaging of Vein and CLCVP in Early Prediction and Intervention CSA-AKI

Not Applicable

Completed

Conditions: Acute Kidney Injury

Interventions: Combination Product: Controlled low central venous pressure (CLCVP) technology
Drug: Nitroglycerin

First Posted Date: 2023-01-12

Last Posted Date: 2023-01-12

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 137

Registration Number: NCT05682716

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

The Effect of Probiotics on Gut Microbiotain After Helicobacter Pylori Eradication

Phase 4

Not yet recruiting

Conditions: Helicobacter Pylori Infection
Infections
Intestinal Bacteria Flora Disturbance

Interventions: Drug: Vonoprazan
Drug: Amoxicillin
Drug: probiotics

First Posted Date: 2022-12-20

Last Posted Date: 2023-02-08

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 100

Registration Number: NCT05658055

Locations: 🇨🇳
Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu

Recruiting

Conditions: Helicobacter Pylori Infection

First Posted Date: 2022-12-16

Last Posted Date: 2023-08-16

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 4000

Registration Number: NCT05654857

Locations: 🇨🇳
The 1st people's hospital of Lianyungang, Lianyungang, Jiangsu, China
🇨🇳
Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
🇨🇳
The Affiliated Shuyang Hospital of Xuzhou Medical University, Suqian, Jiangsu, China

and more 13 locations

Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori

Phase 4

Completed

Conditions: Helicobacter Pylori Infection

Interventions: Drug: Vonoprazan
Drug: Amoxicillin

First Posted Date: 2022-12-14

Last Posted Date: 2024-11-19

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 900

Registration Number: NCT05649540

Locations: 🇨🇳
Changzhou Traditional Chinese Medicine Hospital, Changzhou, Jiangsu, China
🇨🇳
Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
🇨🇳
The Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang, Jiangsu, China

and more 10 locations

Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes

Phase 3

Recruiting

Conditions: Type 2 Diabetes
Blood Glucose Fluctuation

Interventions: Drug: Metformin plus pioglitazone
Drug: Acarbose

First Posted Date: 2022-11-29

Last Posted Date: 2022-11-29

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 50

Registration Number: NCT05629806

Locations: 🇨🇳
Nanjing First Hospital, Nanjing Medical Univesity, Nanjing, China

The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients

Phase 4

Recruiting

Conditions: Type2 Diabetes Mellitus

Interventions: Drug: Polyethylene Glycol Losenatide

First Posted Date: 2022-11-10

Last Posted Date: 2022-11-10

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 480

Registration Number: NCT05611684

Locations: 🇨🇳
Jianhua Ma, Nanjing, Jiangsu, China

Effect of Postoperative Oral Carbohydrate Administration in Total Knee Arthroplasty Elderly Patients

Early Phase 1

Active, not recruiting

Conditions: Total Knee Arthroplasty
Postoperative Oral Carbohydrates
Elderly Patients
Postoperative Recovery

Interventions: Combination Product: 100ml carbohydrate containing 12.5g maltodextrin, fructose and glucose
Other: Routine feeding

First Posted Date: 2022-11-02

Last Posted Date: 2023-05-01

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 64

Registration Number: NCT05603364

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes

Phase 3

Not yet recruiting

Conditions: Insulin Resistance
Type2diabetes

Interventions: Drug: Dapagliflozin
Drug: Metformin
Drug: Fixed-dose combination of metformin and pioglitazone (500mg metformin plus 15mg pioglitazone)

First Posted Date: 2022-10-24

Last Posted Date: 2022-10-24

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 60

Registration Number: NCT05591235

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy